RDHL - RedHill Biopharma Ltd.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/201412/31/2013
Total Revenue--7,000-
Cost of Revenue--1,000-
Gross Profit--6,000-
Operating Expenses
Research Development----
Selling General and Administrative----
Non Recurring----
Others----
Total Operating Expenses31,00022,00018,00011,000
Operating Income or Loss-31,000-22,000-11,000-11,000
Income from Continuing Operations
Total Other Income/Expenses Net----
Earnings Before Interest and Taxes-31,000-22,000-11,000-11,000
Interest Expense----
Income Before Tax----
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops----
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-29,000-21,000-11,000-11,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares----